| Product Code: ETC7558459 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Indonesia Apixaban Market Overview |
3.1 Indonesia Country Macro Economic Indicators |
3.2 Indonesia Apixaban Market Revenues & Volume, 2021 & 2031F |
3.3 Indonesia Apixaban Market - Industry Life Cycle |
3.4 Indonesia Apixaban Market - Porter's Five Forces |
3.5 Indonesia Apixaban Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.6 Indonesia Apixaban Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.7 Indonesia Apixaban Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Indonesia Apixaban Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of atrial fibrillation and venous thromboembolism in Indonesia |
4.2.2 Growing awareness about the benefits of apixaban over traditional anticoagulants |
4.2.3 Favorable government initiatives promoting cardiovascular health awareness and treatment |
4.3 Market Restraints |
4.3.1 High cost associated with apixaban compared to other anticoagulants |
4.3.2 Limited access to healthcare facilities and specialized treatment centers in certain regions of Indonesia |
4.3.3 Stringent regulatory requirements and approval processes for new pharmaceutical products in the Indonesian market |
5 Indonesia Apixaban Market Trends |
6 Indonesia Apixaban Market, By Types |
6.1 Indonesia Apixaban Market, By Dosage Form |
6.1.1 Overview and Analysis |
6.1.2 Indonesia Apixaban Market Revenues & Volume, By Dosage Form, 2021- 2031F |
6.1.3 Indonesia Apixaban Market Revenues & Volume, By Capsule, 2021- 2031F |
6.1.4 Indonesia Apixaban Market Revenues & Volume, By Tablets, 2021- 2031F |
6.2 Indonesia Apixaban Market, By End-Users |
6.2.1 Overview and Analysis |
6.2.2 Indonesia Apixaban Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 Indonesia Apixaban Market Revenues & Volume, By Homecare, 2021- 2031F |
6.2.4 Indonesia Apixaban Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.2.5 Indonesia Apixaban Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Indonesia Apixaban Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Indonesia Apixaban Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 Indonesia Apixaban Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.3.4 Indonesia Apixaban Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.3.5 Indonesia Apixaban Market Revenues & Volume, By Others, 2021- 2031F |
7 Indonesia Apixaban Market Import-Export Trade Statistics |
7.1 Indonesia Apixaban Market Export to Major Countries |
7.2 Indonesia Apixaban Market Imports from Major Countries |
8 Indonesia Apixaban Market Key Performance Indicators |
8.1 Number of new atrial fibrillation and venous thromboembolism cases diagnosed annually |
8.2 Percentage increase in prescriptions of apixaban by healthcare providers in Indonesia |
8.3 Patient adherence rate to apixaban treatment regimen |
8.4 Number of healthcare facilities offering apixaban treatment options |
8.5 Rate of adoption of apixaban as a preferred anticoagulant in Indonesia |
9 Indonesia Apixaban Market - Opportunity Assessment |
9.1 Indonesia Apixaban Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.2 Indonesia Apixaban Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.3 Indonesia Apixaban Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Indonesia Apixaban Market - Competitive Landscape |
10.1 Indonesia Apixaban Market Revenue Share, By Companies, 2024 |
10.2 Indonesia Apixaban Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |